Compile Data Set for Download or QSAR
maximum 50k data
Found 29 Enz. Inhib. hit(s) with all data for entry = 6112
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109264(US8609710, 40)
Affinity DataIC50:  2.60nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109265(US8609710, 35 (2S,4R form))
Affinity DataIC50:  5.10nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109258(US8609710, 34 (2S,4S form))
Affinity DataIC50:  5.40nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109254(US8609710, 25)
Affinity DataIC50:  7nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109256(US8609710, 33)
Affinity DataIC50:  7.5nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109252(US8609710, 15 (2S form))
Affinity DataIC50:  7.80nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109253(US8609710, 24)
Affinity DataIC50:  8.10nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109238(US8609710, 2)
Affinity DataIC50:  8.30nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109239(US8609710, 3)
Affinity DataIC50:  8.80nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109263(US8609710, 39)
Affinity DataIC50:  9.30nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109262(US8609710, 38)
Affinity DataIC50:  9.80nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109260(US8609710, 36)
Affinity DataIC50:  10nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109249(US8609710, 13)
Affinity DataIC50:  12nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109250(US8609710, 14)
Affinity DataIC50:  13nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109247(US8609710, 11)
Affinity DataIC50:  14nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109240(US8609710, 4)
Affinity DataIC50:  14nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109245(US8609710, 9)
Affinity DataIC50:  18nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109244(US8609710, 8)
Affinity DataIC50:  19nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109261(US8609710, 37)
Affinity DataIC50:  19nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109246(US8609710, 10)
Affinity DataIC50:  21nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109255(US8609710, 26)
Affinity DataIC50:  21nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109242(US8609710, 6)
Affinity DataIC50:  21nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109237(US8609710, 1)
Affinity DataIC50:  21nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109248(US8609710, 12)
Affinity DataIC50:  25nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109243(US8609710, 7)
Affinity DataIC50:  26nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109257(US8609710, 34 (2R,4S form))
Affinity DataIC50:  34nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109241(US8609710, 5)
Affinity DataIC50:  35nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109251(US8609710, 15 (2R form))
Affinity DataIC50: >100nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109259(US8609710, 35 (2R,4R form))
Affinity DataIC50: >100nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent